Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 5/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | FCER2 | P06734 | 2/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | HPGDS | O60760 | 3/20 | 0.50 |
| ▸ | CTSS | P25774 | 2/20 | 0.50 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22749410 | 1.00 | OPRD1 (0.52) | OPRD1OPRM1OPRK1FCER2MMP1 | |
| SCHEMBL11191380 | 0.88 | ACE (0.56) | CTSSCTSK | |
| SCHEMBL11191376 | 0.88 | ACE (0.56) | CTSSCTSK | |
| SCHEMBL19889377 | 0.88 | HPGDS (0.46) | OPRD1OPRM1OPRK1FCER2MMP1 | |
| SCHEMBL9419204 | 0.86 | OPRD1 (0.61) | OPRD1OPRM1OPRK1FCER2MMP1 | |
| SCHEMBL20646451 | 0.86 | FCER2 (0.49) | OPRD1OPRM1OPRK1FCER2MMP1 | |
| SCHEMBL9419209 | 0.86 | OPRD1 (0.61) | OPRD1OPRM1OPRK1FCER2MMP1 | |
| SCHEMBL15003956 | 0.86 | QRFPR (0.56) | FCER2MMP1HPGDS | |
| SCHEMBL17177755 | 0.86 | QRFPR (0.56) | FCER2MMP1HPGDS | |
| SCHEMBL16602248 | 0.85 | HDAC3 (0.55) | FCER2MMP1HPGDSCTSSALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12625144-B2 | Chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule | Indian Institute Of Science Education And Research Bhopal (IN) | 2026-05-12 | — | — | US | disclosed |
| US-20220299521-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Indian Institute Of Science Education And Research Bhopal (IN) | 2022-09-22 | — | — | US | disclosed |
| WO-2020245843-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Indian Institute Of Science Education And Research Bhopal (IN) | 2020-12-10 | — | — | WO | disclosed |
| WO-2020245843-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Indian Institute Of Science Education And Research Bhopal (IN) | 2020-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220299521-A1 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | PTMS, PA2G4, MAX | OPRD1 4377/4885OPRM1 4396/4885OPRK1 4673/4885 |
| US-12625144-B2 | Chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule | DPYSL3, CD2BP2, PTMS | OPRD1 2716/4885OPRM1 919/4885OPRK1 2867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.